Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Genomic Characterization
100%
Immune Checkpoint Blockade
100%
Clinical Characterization
100%
Long-term Responders
100%
Immune Checkpoint Inhibitors
85%
Overall Survival
28%
Non-responders
28%
Time-to-treatment
28%
Tumor
14%
No Significant Difference
14%
Prospective Cohort Study
14%
Between-group
14%
Non-associated
14%
Fisher's Exact Test
14%
Programmed Death-ligand 1 (PD-L1)
14%
Durable Response
14%
Liver Metastasis
14%
First-line Therapy
14%
Electronic Medical Records
14%
Second-line Therapy
14%
KRAS mutant
14%
Mann-Whitney Test
14%
Covariables
14%
Long-term Response
14%
Clinical Determinants
14%
Genomic Footprints
14%
Prolonged Response
14%
Real-life Cohort
14%
Genomic Determinants
14%
IrAE
14%
Medicine and Dentistry
Lung Cancer
100%
Immune Checkpoint Blockade
100%
Immune Checkpoint Inhibitor
100%
Overall Survival
33%
Neoplasm
16%
Body Mass Index
16%
Prospective Cohort Study
16%
Biological Marker
16%
Retrospective Study
16%
Fisher Exact Test
16%
Rank Sum Test
16%
Liver Metastasis
16%
Electronic Patient Record
16%
Programmed Death-Ligand 1
16%
Non-Small Cell Lung Cancer
16%
Biochemistry, Genetics and Molecular Biology
Immune Checkpoints
100%
Overall Survival
28%
Retrospective Study
14%
Prospective Cohort Study
14%
KRAS
14%
Electronic Medical Record
14%
Mann-Whitney U Test
14%
PD-L1
14%